These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 6351618)

  • 1. Diabetes mellitus, moderate renal insufficiency and hyperkalemia.
    Glassock RJ; Goldstein DA; Goldstone R; Hsueh WA
    Am J Nephrol; 1983; 3(4):233-40. PubMed ID: 6351618
    [No Abstract]   [Full Text] [Related]  

  • 2. Hyperkalemia and hyporeninemic hypoaldosteronism.
    DeFronzo RA
    Kidney Int; 1980 Jan; 17(1):118-34. PubMed ID: 6990088
    [No Abstract]   [Full Text] [Related]  

  • 3. Hyperkalemia in a diabetic due to renal tubular unresponsiveness to aldosterone.
    Bannister KM; Barratt LJ
    Aust N Z J Med; 1982 Feb; 12(1):63-6. PubMed ID: 7044358
    [No Abstract]   [Full Text] [Related]  

  • 4. Hyporeninemia and hypoaldosteronism in diabetes mellitus.
    Perez GO; Lespier L; Jacobi J; Oster JR; Katz FH; Vaamonde CA; Fishman LM
    Arch Intern Med; 1977 Jul; 137(7):852-5. PubMed ID: 879919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potassium handling by the kidney. Hyperkalaemia.
    Barratt LJ
    Aust N Z J Med; 1981; 11(Suppl 1):16-22. PubMed ID: 7020667
    [No Abstract]   [Full Text] [Related]  

  • 6. The defense against hyperkalemia: the roles of insulin and aldosterone.
    Cox M; Sterns RH; Singer I
    N Engl J Med; 1978 Sep; 299(10):525-32. PubMed ID: 355876
    [No Abstract]   [Full Text] [Related]  

  • 7. Potassium homeostasis in chronic diabetes mellitus.
    Perez GO; Lespier L; Knowles R; Oster JR; Vaamonde CA
    Arch Intern Med; 1977 Aug; 137(8):1018-22. PubMed ID: 327962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hyporeninemic hypoaldosteronism and the differential diagnosis of hyperkalemia].
    Weidmann P
    Schweiz Med Wochenschr; 1982 Dec; 112(49):1764-74. PubMed ID: 6758113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyporeninemic hypoaldosteronism, sodium wasting and mineralocorticoid-resistant hyperkalemia in two patients with obstructive uropathy.
    Pelleya R; Oster JR; Perez GO
    Am J Nephrol; 1983; 3(4):223-7. PubMed ID: 6351617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A case of normotensive hypokalemia similar to Liddle's syndrome with episodic and paroxysmal hyperkalemia].
    Yoshida S; Sakura H; Takaichi K; Uchida S; Yamashita N; Kurokawa K; Ogata E
    Nihon Naika Gakkai Zasshi; 1986 Mar; 75(3):420-5. PubMed ID: 3528355
    [No Abstract]   [Full Text] [Related]  

  • 11. The syndrome of hypertension and hyperkalemia with normal GFR (Gordon's syndrome): is there increased proximal sodium reabsorption?
    Klemm SA; Gordon RD; Tunny TJ; Thompson RE
    Clin Invest Med; 1991 Dec; 14(6):551-8. PubMed ID: 1838973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reversal of glucose-induced hyperkalemia by sodium restriction in normaldosteronemic diabetes: evidence for elevated mineralocorticoid threshold.
    Rado JP
    Biomedicine; 1981 Sep; 35(4):109-11. PubMed ID: 7295860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypoaldosteronism without hyperkalemia.
    Weidmann P; Beretta-Piccoli C; Glück Z; Keusch G; Reubi FC; De Châtel R; Cottier C
    Klin Wochenschr; 1980 Feb; 58(4):185-94. PubMed ID: 6991789
    [No Abstract]   [Full Text] [Related]  

  • 14. Glucose-induced hyperkalemia in diabetic subjects.
    Nicolis GL; Kahn T; Sanchez A; Gabrilove JL
    Arch Intern Med; 1981 Jan; 141(1):49-53. PubMed ID: 7447584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucose-induced paradoxical hyperkalemia in patients with suppression of the renin-aldosterone system: prevention by sodium depletion.
    Radó JP
    J Endocrinol Invest; 1979; 2(4):401-6. PubMed ID: 395185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New approaches to hyperkalemia in patients with indications for renin angiotensin aldosterone inhibitors: Considerations for trial design and regulatory approval.
    Zannad F; Rossignol P; Stough WG; Epstein M; Alonso Garcia Mde L; Bakris GL; Butler J; Kosiborod M; Berman L; Mebazaa A; Rasmussen HS; Ruilope LM; Stockbridge N; Thompson A; Wittes J; Pitt B
    Int J Cardiol; 2016 Aug; 216():46-51. PubMed ID: 27140336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperkalemia and renin production.
    Flamenbaum W; Kotchen TA
    N Engl J Med; 1972 Nov; 287(22):1151. PubMed ID: 5082204
    [No Abstract]   [Full Text] [Related]  

  • 18. [Review on internal medicine, 1984. Electrolyte disturbance. II-3. Hyperkalemia in hyporeninemic hypoaldosteronism].
    Saruta T
    Nihon Naika Gakkai Zasshi; 1985 Jun; 74(6):708-12. PubMed ID: 3900256
    [No Abstract]   [Full Text] [Related]  

  • 19. Plasma aldosterone in terminal renal failure.
    Weidmann P; Maxwell MH; Lupu AN
    Ann Intern Med; 1973 Jan; 78(1):13-8. PubMed ID: 4682294
    [No Abstract]   [Full Text] [Related]  

  • 20. Big renin and biosynthetic defect of aldosterone in diabetes mellitus.
    deLeiva A; Christlieb AR; Melby JC; Graham CA; Day RP; Luetscher JA; Zager PG
    N Engl J Med; 1976 Sep; 295(12):639-43. PubMed ID: 184384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.